Literature DB >> 23411029

The "Vampirome": Transcriptome and proteome analysis of the principal and accessory submaxillary glands of the vampire bat Desmodus rotundus, a vector of human rabies.

Ivo M B Francischetti1, Teresa C F Assumpção, Dongying Ma, Yuan Li, Eliane C Vicente, Wilson Uieda, José M C Ribeiro.   

Abstract

Vampire bats are notorious for being the sole mammals that strictly feed on fresh blood for their survival. While their saliva has been historically associated with anticoagulants, only one antihemostatic (plasminogen activator) has been molecularly and functionally characterized. Here, RNAs from both principal and accessory submaxillary (submandibular) salivary glands of Desmodus rotundus were extracted, and ~200 million reads were sequenced by Illumina. The principal gland was enriched with plasminogen activators with fibrinolytic properties, members of lipocalin and secretoglobin families, which bind prohemostatic prostaglandins, and endonucleases, which cleave neutrophil-derived procoagulant NETs. Anticoagulant (tissue factor pathway inhibitor, TFPI), vasodilators (PACAP and C-natriuretic peptide), and metalloproteases (ADAMTS-1) were also abundantly expressed. Members of the TSG-6 (anti-inflammatory), antigen 5/CRISP, and CCL28-like (antimicrobial) protein families were also sequenced. Apyrases (which remove platelet agonist ADP), phosphatases (which degrade procoagulant polyphosphates), and sphingomyelinase were found at lower transcriptional levels. Accessory glands were enriched with antimicrobials (lysozyme, defensin, lactotransferrin) and protease inhibitors (TIL-domain, cystatin, Kazal). Mucins, heme-oxygenase, and IgG chains were present in both glands. Proteome analysis by nano LC-MS/MS confirmed that several transcripts are expressed in the glands. The database presented herein is accessible online at http://exon.niaid.nih.gov/transcriptome/D_rotundus/Supplemental-web.xlsx. These results reveal that bat saliva emerges as a novel source of modulators of vascular biology. BIOLOGICAL SIGNIFICANCE: Vampire bat saliva emerges as a novel source of antihemostatics which modulate several aspects of vascular biology. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23411029      PMCID: PMC3685427          DOI: 10.1016/j.jprot.2013.01.009

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  135 in total

Review 1.  Biological activities of C1 inhibitor.

Authors:  Alvin E Davis; Pedro Mejia; Fengxin Lu
Journal:  Mol Immunol       Date:  2008-07-31       Impact factor: 4.407

Review 2.  Regulation of proteases by protein inhibitors of the serpin superfamily.

Authors:  Steven T Olson; Peter G W Gettins
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

3.  Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins.

Authors:  M D Tortorella; T C Burn; M A Pratta; I Abbaszade; J M Hollis; R Liu; S A Rosenfeld; R A Copeland; C P Decicco; R Wynn; A Rockwell; F Yang; J L Duke; K Solomon; H George; R Bruckner; H Nagase; Y Itoh; D M Ellis; H Ross; B H Wiswall; K Murphy; M C Hillman; G F Hollis; R C Newton; R L Magolda; J M Trzaskos; E C Arner
Journal:  Science       Date:  1999-06-04       Impact factor: 47.728

4.  VIP/PACAP receptor mediation of cutaneous active vasodilation during heat stress in humans.

Authors:  Dean L Kellogg; Joan L Zhao; Yubo Wu; John M Johnson
Journal:  J Appl Physiol (1985)       Date:  2010-04-15

5.  METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity.

Authors:  F Vázquez; G Hastings; M A Ortega; T F Lane; S Oikemus; M Lombardo; M L Iruela-Arispe
Journal:  J Biol Chem       Date:  1999-08-13       Impact factor: 5.157

6.  Dipetalodipin, a novel multifunctional salivary lipocalin that inhibits platelet aggregation, vasoconstriction, and angiogenesis through unique binding specificity for TXA2, PGF2alpha, and 15(S)-HETE.

Authors:  Teresa C F Assumpção; Patricia H Alvarenga; José M C Ribeiro; John F Andersen; Ivo M B Francischetti
Journal:  J Biol Chem       Date:  2010-10-02       Impact factor: 5.157

Review 7.  Venomous mammals: a review.

Authors:  Rodrigo Ligabue-Braun; Hugo Verli; Célia Regina Carlini
Journal:  Toxicon       Date:  2012-03-03       Impact factor: 3.033

8.  Regulation of transcripts encoding ADAMTS-1 (a disintegrin and metalloproteinase with thrombospondin-like motifs-1) and progesterone receptor by human chorionic gonadotropin in equine preovulatory follicles.

Authors:  D Boerboom; D L Russell; J S Richards; J Sirois
Journal:  J Mol Endocrinol       Date:  2003-12       Impact factor: 5.098

Review 9.  Histatins: antimicrobial peptides with therapeutic potential.

Authors:  Kevin Kavanagh; Susan Dowd
Journal:  J Pharm Pharmacol       Date:  2004-03       Impact factor: 3.765

10.  Plasminogen activator in saliva of the vampire bat Desmodus rotundus.

Authors:  C Hawkey
Journal:  Nature       Date:  1966-07-23       Impact factor: 49.962

View more
  19 in total

1.  Desmolaris, a novel factor XIa anticoagulant from the salivary gland of the vampire bat (Desmodus rotundus) inhibits inflammation and thrombosis in vivo.

Authors:  Dongying Ma; Daniella M Mizurini; Teresa C F Assumpção; Yuan Li; Yanwei Qi; Michail Kotsyfakis; José M C Ribeiro; Robson Q Monteiro; Ivo M B Francischetti
Journal:  Blood       Date:  2013-10-24       Impact factor: 22.113

2.  Salivary antigen-5/CAP family members are Cu2+-dependent antioxidant enzymes that scavenge O₂₋. and inhibit collagen-induced platelet aggregation and neutrophil oxidative burst.

Authors:  Teresa C F Assumpção; Dongying Ma; Alexandra Schwarz; Karine Reiter; Jaime M Santana; John F Andersen; José M C Ribeiro; Glenn Nardone; Lee L Yu; Ivo M B Francischetti
Journal:  J Biol Chem       Date:  2013-04-05       Impact factor: 5.157

3.  Adaptive Evolution of C-Type Lysozyme in Vampire Bats.

Authors:  Chunzheng He; Yujia Wei; Yubo Zhu; Yu Xia; David M Irwin; Yang Liu
Journal:  J Mol Evol       Date:  2019-09-10       Impact factor: 2.395

4.  Identification of Novel Toxin Genes from the Stinging Nettle Caterpillar Parasa lepida (Cramer, 1799): Insights into the Evolution of Lepidoptera Toxins.

Authors:  Natrada Mitpuangchon; Kwan Nualcharoen; Singtoe Boonrotpong; Patamarerk Engsontia
Journal:  Insects       Date:  2021-04-29       Impact factor: 2.769

5.  Arachnids of medical importance in Brazil: main active compounds present in scorpion and spider venoms and tick saliva.

Authors:  Francielle A Cordeiro; Fernanda G Amorim; Fernando A P Anjolette; Eliane C Arantes
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2015-08-13

6.  Systems Biomedicine of Rabies Delineates the Affected Signaling Pathways.

Authors:  Sadegh Azimzadeh Jamalkandi; Sayed-Hamidreza Mozhgani; Hamid Gholami Pourbadie; Mehdi Mirzaie; Farshid Noorbakhsh; Behrouz Vaziri; Alireza Gholami; Naser Ansari-Pour; Mohieddin Jafari
Journal:  Front Microbiol       Date:  2016-11-07       Impact factor: 5.640

7.  Are Fireworms Venomous? Evidence for the Convergent Evolution of Toxin Homologs in Three Species of Fireworms (Annelida, Amphinomidae).

Authors:  Aida Verdes; Danny Simpson; Mandë Holford
Journal:  Genome Biol Evol       Date:  2018-01-01       Impact factor: 3.416

8.  Are ticks venomous animals?

Authors:  Alejandro Cabezas-Cruz; James J Valdés
Journal:  Front Zool       Date:  2014-07-01       Impact factor: 3.172

9.  A Polychaete's powerful punch: venom gland transcriptomics of Glycera reveals a complex cocktail of toxin homologs.

Authors:  Björn M von Reumont; Lahcen I Campbell; Sandy Richter; Lars Hering; Dan Sykes; Jörg Hetmank; Ronald A Jenner; Christoph Bleidorn
Journal:  Genome Biol Evol       Date:  2014-09-05       Impact factor: 3.416

10.  Evidence for a lectin specific for sulfated glycans in the salivary gland of the malaria vector, Anopheles gambiae.

Authors:  Ivo M B Francischetti; Dongying Ma; John F Andersen; José M C Ribeiro
Journal:  PLoS One       Date:  2014-09-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.